# Memantine as an Additive Therapy in Patients With Traumatic Brain Injury

> **NCT06914310** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Mansoura University** · enrollment: 80 (estimated)

## Conditions studied

- Mild Traumatic Brain Injury
- Moderate Traumatic Brain Injury (TBI)

## Interventions

- **DRUG:** Memantine
- **DRUG:** Mannitol

## Key facts

- **NCT ID:** NCT06914310
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914310, "Memantine as an Additive Therapy in Patients With Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06914310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*